PreveCeutical Medical Statistics
Total Valuation
PRVCF has a market cap or net worth of 12.40 million. The enterprise value is 15.73 million.
| Market Cap | 12.40M |
| Enterprise Value | 15.73M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 570.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 464.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.28 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -47.73 |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -9.71 |
| Interest Coverage | -3.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -360.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 17.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +102.60% in the last 52 weeks. The beta is -0.01, so PRVCF's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +102.60% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 52.26 |
| Average Volume (20 Days) | 23,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -894,292 |
| Pretax Income | -1.18M |
| Net Income | -1.18M |
| EBITDA | -886,779 |
| EBIT | -894,292 |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 3,809 in cash and 3.20 million in debt, giving a net cash position of -3.20 million.
| Cash & Cash Equivalents | 3,809 |
| Total Debt | 3.20M |
| Net Cash | -3.20M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.02M |
| Book Value Per Share | -0.01 |
| Working Capital | -5.09M |
Cash Flow
In the last 12 months, operating cash flow was -328,823 and capital expenditures -710, giving a free cash flow of -329,533.
| Operating Cash Flow | -328,823 |
| Capital Expenditures | -710 |
| Free Cash Flow | -329,533 |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRVCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | n/a |
| Earnings Yield | -9.55% |
| FCF Yield | -2.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 23, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |